Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $202B | +$3.06B | 198 | 2.92% | Increased |
|
| 2 |
BlackRock
New York
| $181B | +$4.25B | 213 | 3.06% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $101B | +$1.86B | 184 | 3.38% | Increased |
|
| 4 |
Geode Capital Management
Boston,
Massachusetts
| $49.7B | +$2.12B | 222 | 3.07% | Increased |
|
| 5 |
JP Morgan Chase
New York
| $43.5B | -$2.58B | 176 | 2.73% | Reduced |
|
| 6 |
Morgan Stanley
New York
| $43.2B | -$128M | 235 | 2.58% | Reduced |
|
| 7 |
Fidelity Investments
Boston,
Massachusetts
| $41.3B | +$1.84B | 153 | 2.1% | Increased |
|
| 8 |
Norges Bank
Oslo,
Norway
| $28.3B | +$27B | 35 | 3.03% | New |
|
| 9 |
Wellington Management Group
Boston,
Massachusetts
| $28.2B | -$905M | 71 | 4.94% | Reduced |
|
| 10 |
Bank of America
Charlotte,
North Carolina
| $27.9B | +$275M | 241 | 2.03% | Increased |
|
| 11 |
Charles Schwab
San Francisco,
California
| $27.2B | -$1.2B | 112 | 4.23% | Reduced |
|
| 12 |
Invesco
Atlanta,
Georgia
| $26B | +$10.3B | 108 | 2.45% | Increased |
|
| 13 |
Northern Trust
Chicago,
Illinois
| $23.9B | -$378M | 185 | 3.04% | Reduced |
|
| 14 |
T. Rowe Price Associates
Baltimore,
Maryland
| $23.6B | +$1.77B | 107 | 2.55% | Increased |
|
| 15 |
Capital World Investors
Los Angeles,
California
| $20.5B | +$2.83B | 12 | 2.79% | Increased |
|
| 16 |
Goldman Sachs
New York
| $18.6B | +$2.09B | 146 | 2.28% | Increased |
|
| 17 |
Bank of New York Mellon
New York
| $17.8B | +$944M | 114 | 3.14% | Increased |
|
| 18 |
Franklin Resources
San Mateo,
California
| $16.3B | -$833M | 74 | 3.99% | Reduced |
|
| 19 |
UBS AM
Chicago,
Illinois
| $15.4B | +$398M | 82 | 3.26% | Increased |
|
| 20 |
Dimensional Fund Advisors
Austin,
Texas
| $15.2B | -$355M | 103 | 3.2% | Reduced |
|
| 21 |
Capital International Investors
Los Angeles,
California
| $14.9B | -$1.61B | 13 | 2.34% | Reduced |
|
| 22 |
Legal & General Group
London,
United Kingdom
| $14.5B | -$170M | 103 | 3.21% | Reduced |
|
| 23 |
Dodge & Cox
San Francisco,
California
| $13.5B | -$1.19B | 13 | 7.26% | Reduced |
|
| 24 |
Ameriprise
Minneapolis,
Minnesota
| $13B | +$347M | 87 | 2.94% | Increased |
|
| 25 |
UBS Group
Zurich,
Switzerland
| $12.3B | -$472M | 258 | 2% | Reduced |
|